Cargando…

Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice

BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix me...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jun, Wang, Penghua, Wang, Tong, Wang, Meijun, Chen, Sisi, Yu, Pei, Yu, Demin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166470/
https://www.ncbi.nlm.nih.gov/pubmed/25204377
http://dx.doi.org/10.1186/1471-2261-14-114
_version_ 1782335279315550208
author Xu, Jun
Wang, Penghua
Wang, Tong
Wang, Meijun
Chen, Sisi
Yu, Pei
Yu, Demin
author_facet Xu, Jun
Wang, Penghua
Wang, Tong
Wang, Meijun
Chen, Sisi
Yu, Pei
Yu, Demin
author_sort Xu, Jun
collection PubMed
description BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the aortas of diabetic mice. METHODS: We provided 120 female 8-week-old Balb/c mice with a high sugar, high fat diet. After 8 weeks they were injected with streptozotocin to induce diabetes. We treated mice in the mono dose groups with β(2)GP I, reduced β(2)GP I, or phosphate-buffered saline (PBS) on day 1 and fed them for 3 weeks. The mice in the complex dose groups were treated with β(2)GP I, reduced β(2)GP I, or PBS on days 1 and 22 and fed for 6 weeks. Control mice were given a standard chow diet. Blood lipids were measured at the end of 3 or 6 weeks, and aortas removed to observe morphological and molecular biological changes. RESULTS: The low-density lipoprotein cholesterol levels in mice of the reduced β(2)GP I group were lower than those in the diabetic group. Aortic lipid deposition in the reduced β(2)GP I group was significantly less than in the diabetic control group. In the aortas, reduced β(2)GP I decreased MMP2/TIMP2 mRNA and protein expression levels, and MMP9/TIMP1 expression levels compared with those in diabetic controls. Reduced β(2)GP I down-regulated p38 mitogen-activated protein kinase (p38MAPK) mRNA expression and phosphorylated p38MAPK protein expression compared with those in diabetic controls of the complex dose group. CONCLUSIONS: Reduced β(2)GP I plays a role in diabetic mice related to vascular protection, inhibiting vascular lipid deposition, and plaque formation by reducing MMPs/TIMPs expression through down-regulation of the p38MAPK signaling pathway.
format Online
Article
Text
id pubmed-4166470
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41664702014-09-19 Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice Xu, Jun Wang, Penghua Wang, Tong Wang, Meijun Chen, Sisi Yu, Pei Yu, Demin BMC Cardiovasc Disord Research Article BACKGROUND: Reduced β(2)-glycoprotein I (reduced β(2)GP I), which has free sulfhydryl groups, is present in plasma and serum; it can protect vascular endothelial cells from damage due to oxidative stress in vitro. We investigated the effects of reduced β(2)GP I on the expression of various matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) in the aortas of diabetic mice. METHODS: We provided 120 female 8-week-old Balb/c mice with a high sugar, high fat diet. After 8 weeks they were injected with streptozotocin to induce diabetes. We treated mice in the mono dose groups with β(2)GP I, reduced β(2)GP I, or phosphate-buffered saline (PBS) on day 1 and fed them for 3 weeks. The mice in the complex dose groups were treated with β(2)GP I, reduced β(2)GP I, or PBS on days 1 and 22 and fed for 6 weeks. Control mice were given a standard chow diet. Blood lipids were measured at the end of 3 or 6 weeks, and aortas removed to observe morphological and molecular biological changes. RESULTS: The low-density lipoprotein cholesterol levels in mice of the reduced β(2)GP I group were lower than those in the diabetic group. Aortic lipid deposition in the reduced β(2)GP I group was significantly less than in the diabetic control group. In the aortas, reduced β(2)GP I decreased MMP2/TIMP2 mRNA and protein expression levels, and MMP9/TIMP1 expression levels compared with those in diabetic controls. Reduced β(2)GP I down-regulated p38 mitogen-activated protein kinase (p38MAPK) mRNA expression and phosphorylated p38MAPK protein expression compared with those in diabetic controls of the complex dose group. CONCLUSIONS: Reduced β(2)GP I plays a role in diabetic mice related to vascular protection, inhibiting vascular lipid deposition, and plaque formation by reducing MMPs/TIMPs expression through down-regulation of the p38MAPK signaling pathway. BioMed Central 2014-09-10 /pmc/articles/PMC4166470/ /pubmed/25204377 http://dx.doi.org/10.1186/1471-2261-14-114 Text en © Xu et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xu, Jun
Wang, Penghua
Wang, Tong
Wang, Meijun
Chen, Sisi
Yu, Pei
Yu, Demin
Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title_full Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title_fullStr Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title_full_unstemmed Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title_short Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
title_sort effects of reduced β(2)-glycoprotein i on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166470/
https://www.ncbi.nlm.nih.gov/pubmed/25204377
http://dx.doi.org/10.1186/1471-2261-14-114
work_keys_str_mv AT xujun effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT wangpenghua effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT wangtong effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT wangmeijun effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT chensisi effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT yupei effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice
AT yudemin effectsofreducedb2glycoproteiniontheexpressionofaorticmatrixmetalloproteinasesandtissueinhibitormatrixmetalloproteinasesindiabeticmice